|
| |
| | | 67359 | | 24.03.2020 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 02 | Piqray 150 mg | Filmtabletten | Coated tablets (Alpelisibum 150 mg) | L01EM03 | CI | | 03 | Piqray 200 mg + 50 mg | Filmtabletten | Coated tablets (Alpelisibum 200 mg) + Coated tablets (Alpelisibum 50 mg) | L01EM03 | | | 04 | Piqray 200 mg | Filmtabletten | Coated tablets (Alpelisibum 200 mg) | L01EM03 | |
|
|
|
